Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 932691, 6 pages
http://dx.doi.org/10.1155/2013/932691
Review Article

Potential of RAS Inhibition to Improve Metabolic Bone Disorders

1Center for Systems Biomedical Sciences, University of Shanghai for Science and Technology, Shanghai 200093, China
2School of Medical Instrument and Food Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China
3Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong

Received 24 May 2013; Accepted 2 July 2013

Academic Editor: John J. Gildea

Copyright © 2013 Yoseph Gebru et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [13 citations]

The following is the list of published articles that have cited the current article.

  • Jeppe Skov, Frederik Persson, Jørgen Frøkiær, and Jens Sandahl Christiansen, “Tissue renin-angiotensin systems: A unifying hypothesis of metabolic disease,” Frontiers in Endocrinology, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Rita de Cassia Marqueti, Nara Yumi Hashimoto, Joao Luiz Quaglioti Durigan, Livia Larissa Batista e Silva, Jeeser Alves de Almeida, Maria da Gloria da Silva, Edilamar Menezes de Oliveira, and Heloisa Sobreiro Selistre de Araujo, “Nandrolone Increases Angiotensin-I Converting Enzyme Activity In Rats Tendons,” Revista Brasileira De Medicina Do Esporte, vol. 21, no. 3, pp. 173–177, 2015. View at Publisher · View at Google Scholar
  • Jin-Xin Liu, Fang-Yi Zhang, and Yan Zhang, “Research progress on regulation of angiotensin II on bone metabolism,” Chinese Pharmacological Bulletin, vol. 31, no. 4, pp. 458–461, 2015. View at Publisher · View at Google Scholar
  • Subhadra Poornima, Krishna Subramanyam, Imran Ali Khan, and Qurratulain Hasan, “The insertion and deletion (I28005D) polymorphism of the angiotensin I converting enzyme gene is a risk factor for osteoarthritis in an Asian Indian p,” Journal Of The Renin-Angiotensin-Aldosterone System, vol. 16, no. 4, pp. 1281–1287, 2015. View at Publisher · View at Google Scholar
  • Timothy Kwok, Jason Leung, and Elizabeth Barrett-Connor, “ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men,” Age and Ageing, 2016. View at Publisher · View at Google Scholar
  • Baris Ozgur Donmez, Mustafa Unal, Semir Ozdemir, Nihal Ozturk, Nurettin Oguz, and Ozan Akkus, “Effects of losartan treatment on the physicochemical properties of diabetic rat bone,” Journal of Bone and Mineral Metabolism, 2016. View at Publisher · View at Google Scholar
  • Liao-Bin Chen, Xian-Rong Zhang, Zheng-Qi Pan, Hao Xiao, Yang-Fan Shang-Guan, and Hui Wang, “Mechanisms of renin-angiotensin system and therapeutic targets of osteoporosis: Research progress,” Chinese Journal of Pharmacology and Toxicology, vol. 30, no. 10, pp. 1114–1119, 2016. View at Publisher · View at Google Scholar
  • Alok S. Tripathi, and Shreesh J. Marathe, “Probiotics and Physical Strength,” Probiotics, Prebiotics, and Synbiotics, pp. 635–640, 2016. View at Publisher · View at Google Scholar
  • Mona M. Allam, and Noha I. Hussien, “A comparative study between the effect of 17-β estradiol & angiotensin converting enzyme inhibitor on osteoporosis in ovariectomized rats,” General Physiology and Biophysics, vol. 35, no. 4, pp. 433–441, 2016. View at Publisher · View at Google Scholar
  • Hanaa H Ahmed, Elshahat A Toson, Hatem A El-mezayen, Laila A Rashed, and Eslam S Elsherbiny, “Role of mesenchymal stem cells versus angiotensin converting enzyme inhibitor in kidney repair,” Nephrology, vol. 22, no. 7, pp. 531–540, 2017. View at Publisher · View at Google Scholar
  • Kaizhong Yan, and Yixin Shen, “Aliskiren has chondroprotective efficacy in a rat model of osteoarthritis through suppression of the local renin-angiotensin system,” Molecular Medicine Reports, vol. 16, no. 4, pp. 3965–3973, 2017. View at Publisher · View at Google Scholar
  • Yan-Zhen Cheng, Shuang-Li Yang, Ji-Yu Wang, Meng Ye, Xiao-Yun Zhuo, Li-Tao Wang, Hong Chen, Hua Zhang, and Li Yang, “Irbesartan attenuates advanced glycation end products-mediated damage in diabetes-associated osteoporosis through the AGEs/RAGE pathway,” Life Sciences, 2018. View at Publisher · View at Google Scholar
  • Ranganath Muniyappa, and Sri Harsha Tella, “Osteoporosis and Cardiovascular Disease in the Elderly,” Conn's Handbook of Models for Human Aging, pp. 721–733, 2018. View at Publisher · View at Google Scholar